Recent Updates
Recently added Catalysts
MDXG Positive Sentiment

MIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026

Key Takeaway: MiMedx Group, Inc. will announce its third quarter financial results on October 28, 2026. The announcement will be followed by a conference call at 4:30 p.m. ET, where senior management will discuss the results. Investors can access the call via a dedicated phone line or webcast, with a replay available for 30 days.

Market Sentiment Analysis

POSITIVE FACTORS

  • MIMEDX is set to report its financial results, indicating transparency.
  • The company continues to focus on innovation in healing solutions.
  • The conference call provides an opportunity for investor engagement.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~38 mo
Low dilution risk
Lead asset
Micronized dHACM
Phase 2 · Knee Osteoarthritis

Full Press Release Details

MARIETTA, Ga., Oct. 14, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third quarter ended September 30, 2026 after the market close on Wednesday, October 28, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here U.S. Investors: 877-407-6184 International Investors: 201-389-0877 Conference ID: 13762954
A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.
About MIMEDX MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Contact: Matt Notarianni Investor Relations 470-304-7291 mnotarianni@mimedx.com

Frequently Asked Questions

When will MIMEDX report its Q3 2026 results?

MIMEDX will report its Q3 2026 results on October 28, 2026.

What time is the MIMEDX conference call?

The conference call will begin at 4:30 p.m. Eastern Time.

How can investors access the conference call?

Investors can access the call via a dedicated phone line or webcast.

Is there a replay available for the conference call?

Yes, a replay will be available for approximately 30 days on MIMEDX's website.

Last updated: Oct 14, 2026